Form D · Other Health Care

Reprieve Cardiovascular, Inc.

Milford, MA · CIK 0001820102

Offering snapshot reported Jun 5, 2025 · SEC filing

Reported sold
$30.9M
Offering amount: $35.9M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 28, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 5, 2025Initial$30,852,111No comparison12SEC filing
Jan 27, 2025Amendment$9,522,886$4,522,887vs Oct 2, 20248SEC filing
Oct 2, 2024Initial$4,999,999No comparison8SEC filing
Nov 20, 2023Initial$12,050,001No comparison7SEC filing
Jun 8, 2022Initial$15,000,000No comparison6SEC filing
Aug 4, 2020Initial$15,000,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-548181

Source: Form D, filed Jun 5, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Adam Bartnik Executive
Ethan Benovitz Director
Jim Dillon Director, Executive
James Eadie Director
Andrew El Bardissi Director
Tony Fields Executive
Jan Garfinkle Director
Hanson S. Gifford Iii Director
Gregory W. Mann Executive
David Neustaedter Director
Mark Pacyna Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
459 Fortune Boulevard
Milford, MA, 01757